Top Markets
Coin of the day
Decision Diagnostics Corp. Decision Diagnostics Corp.

Decision Diagnostics Corp.

DECN
주식 순위 #41200
Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake... Decision Diagnostics Corp. (DECN), founded in 2000 and based in Westlake Village, California, specializes in developing electronic medical record (EMR) technologies primarily optimized for smartphones. The company provides a wide array of offerings, including both regulated and unregulated diagnostic solutions, as well as home-use testing products for individuals managing chronic illnesses. They also facilitate direct-to-patient logistics for diabetes programs and concentrate on creating mobile-centric e-health products and associated technological innovations. A key part of their product line involves glucose monitoring. This includes the GenUltimate! glucose test strips, classified as a Class II medical device for personal at-home human use. For animal health, they manufacture PetSure! glucose test strips, designed to measure glucose levels in dogs and cats and compatible with legacy Zoetis AlphaTrak glucometers. Additionally, they offer the proprietary GenUltimate! 4Pets Glucose system, which combines the GenUltimate! 4Pets strip with the Avantage meter, enabling glucose testing for canine, feline, and equine patients. Further glucose strip options include GenUltimate! Sure and GenUltimate! Precis. Beyond product development, Decision Diagnostics actively acquires and maintains a portfolio of intellectual property, spanning patents, trademarks, and specialized manufacturing equipment. Their software solutions include MD@Hand, a comprehensive management system for both inpatient and outpatient care; Practice Probe, a data mining utility designed to extract information from physician practice management systems; and ResidenceWare, a residential management system that streamlines communication between commercial or residential real estate managers and their tenants through networked applications. Ultimately, their EMR innovations provide crucial tools for physicians directly at the point of patient care. The company was originally known as InstaCare Corp. before officially changing its name to Decision Diagnostics Corp. in November 2011.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$35.79K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Decision Diagnostics Corp. (DECN)

카테고리

B의 시가 총액을 가진 DECN의 가격
Decision Diagnostics Corp. Decision Diagnostics Corp.
DECN
$0.0001
의 시가총액 Decision Diagnostics Corp.(DECN)
시가총액: $35.79K
August 2026 기준으로 Decision Diagnostics Corp.의 시가총액은 $35.79K입니다. 이는 당사 데이터에 따르면 Decision Diagnostics Corp.이 세계에서 41200th번째로 가치 있는 기업임을 의미합니다. 시가총액은 상장된 회사의 발행 주식 총 시장 가치를 의미하며, 일반적으로 회사의 가치를 측정하는 데 사용됩니다.
2002부터 2026까지 Decision Diagnostics Corp.의 시가총액 기록
DECN 가장 인기있는 상위 5 가지 stocks과 비교하여
DECN의 가격 자산 b b의 시장 결과
Decision Diagnostics Corp. Decision Diagnostics Corp.
$15,042.78 $35.79K
$5.383T +15,042,779,289.16%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$12,360.33 $35.79K
$4.423T +12,360,329,639.12%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$11,625.37 $35.79K
$4.160T +11,625,364,974.14%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$10,236.46 $35.79K
$3.663T +10,236,456,817.32%
Decision Diagnostics Corp. Decision Diagnostics Corp.
$8,078.99 $35.79K
$2.891T +8,078,991,699.82%